Used in targeted cancer therapy, particularly in the treatment of solid tumors such as non-small cell lung cancer and colorectal cancer. It works by binding to EGFL7, a protein involved in blood vessel formation, thereby inhibiting tumor angiogenesis and reducing tumor growth. It has been investigated in clinical trials to enhance the effectiveness of chemotherapy and other anti-cancer agents by normalizing tumor vasculature and improving drug delivery.